Eye care, like many areas of the health sector, is facing an ongoing personnel shortage. UW Health is addressing the challenge by recruiting, growing, and training its own. The new program is providing eight employees the life-changing opportunity to receive on-the-job training and classroom instruction, while still receiving their salaries and benefits.
All Posts
Coming Full Circle: Former Ophthalmology Patient Works in the Operating Room, Alongside the Doctor Who Treated Her
Fifteen years after her first strabismus surgery, Veronica Witt still finds herself in the UW Health eye clinic every week. But these days, it’s for a much different reason. The 40-year-old year old from Appleton, …
An Updated Simplified Severity Scale for Age-Related Macular Degeneration, Incorporating Reticular Pseudodrusen: Age-Related Eye Disease Study Report No. 42.
PubMed ID: 38657840 Author(s): Agron E, Domalpally A, Chen Q, Lu Z, Chew EY, Keenan TDL; AREDS and AREDS2 Research Groups. An Updated Simplified Severity Scale for Age-Related Macular Degeneration, Incorporating Reticular Pseudodrusen: Age-Related Eye …
DOVS at ARVO 2024
The UW Department of Ophthalmology and Visual Sciences is pleased to have many colleagues presenting and participating at this year’s Association for Research in Vision and Ophthalmology annual meeting in New Orleans, Louisiana.
Nanoparticles subdue antibiotic-resistant bacteria’s defences while enhancing innate immunity
A method for overcoming antibiotic resistance uses multimodal nanoparticles that target bacterial defence mechanisms while enhancing the innate immune response. The rise in antibiotic resistance is considered a slow-moving medical catastrophe, as these revolutionary drugs that have kept us relatively safe from bacterial infection for decades are losing their efficacy. In part due to their co-evolution, bacterial pathogens have developed mechanisms to resist almost every antibiotic on the market and we are in desperate need for new, innovative approaches. Writing in Nature Nanotechnology, Zhu et al. present a nanoparticle-based possibility, in which they target bacterial defence mechanisms while simultaneously enhancing the ability of the host immune cells to fight infection.
Multimodal nanoimmunotherapy engages neutrophils to eliminate Staphylococcus aureus infections.
PubMed ID: 38632494 Author(s): Zhu J, Xie R, Gao R, Zhao Y, Yodsanit N, Zhu M, Burger JC, Ye M, Tong Y, Gong S. Multimodal nanoimmunotherapy engages neutrophils to eliminate Staphylococcus aureus infections. Nat Nanotechnol. …
Peripheral ulcerative keratitis associated with tralokinumab therapy: a case report and review of IL-13 inhibitor-associated ocular surface disease.
PubMed ID: 38625674 Author(s): Maganti N, Whittier SA, Warner EJ. Peripheral ulcerative keratitis associated with tralokinumab therapy: a case report and review of IL-13 inhibitor-associated ocular surface disease. J Ophthalmic Inflamm Infect. 2024 Apr 16;14(1):15. …
Ophthalmology Alumni Association Welcomes New Members
The UW Department of Ophthalmology and Visual Sciences is pleased to welcome three new members to the UW Ophthalmology Alumni Association.
Introducing the 2024 Kambara Symposium Keynote Speaker: Budd Tucker, PhD
A highly accomplished vision scientist and expert in retinal disease will be the keynote speaker at the 2023 George Kambara, MD Vision Science Symposium on Friday, April 14, 2024.